Metastatic Solid Tumors Clinical Trials in the UK

Metastatic Solid Tumors Trials in the UK

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a UK site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full UK registry across all sponsors is far larger. UK studies may also be registered separately on ISRCTN.

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

Clear sponsor filter

Site city

All 7 cities

Target enrolment

Status

Study

Lead sponsor

Phase

Enrol

UK sites

Start

Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

NCT04094610Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma, Primary CNS Tumors

Turning Point Therapeutics, Inc.

Phase 1/2

Liverpool, Birmingham, Cardiff, Glasgow, London

2020-03-12

Recruiting

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

NCT03093116Locally Advanced Solid Tumors, Metastatic Solid Tumors

Turning Point Therapeutics, Inc.

Phase 1/2

500

London, Manchester, Sutton

2017-03-07

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a UK investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 September 2026. https://priyalifescience.com/clinical-trials-uk/condition/metastatic-solid-tumors

Query this register directly

GET /api/trials?country=uk&status=recruiting&format=json Try it now →